Cancer disease progression trang 1 tải miễn phí từ TAILIEUCHUNG

"Cancer disease progression" trang 1 - tải miễn phí từ Tailieuchung

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: Results of the CECOG LaVie trial

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: Results of the CECOG LaVie trial

7 57 1

Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer

Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer

9 41 1

Subtype-Independent ANP32E Reduction During Breast Cancer Progression in Accordance with Chromatin Relaxation

Subtype-Independent ANP32E Reduction During Breast Cancer Progression in Accordance with Chromatin Relaxation

15 45 3

Association between changes in body fat and disease progression after breast cancer surgery is moderated by menopausal status

Association between changes in body fat and disease progression after breast cancer surgery is moderated by menopausal status

7 37 1

High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer

High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer

9 45 0

A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping

A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping

11 38 1

Variable selection for disease progression models: Methods for oncogenetic trees and application to cancer and HIV

Variable selection for disease progression models: Methods for oncogenetic trees and application to cancer and HIV

16 47 1

Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: A subanalysis from a phase 3 trial (MPACT)

10 51 1

Cost-effectiveness analysis of cabazitaxel for metastatic castration resistant prostate cancer after docetaxel and androgensignaling-targeted inhibitor resistance

Cost-effectiveness analysis of cabazitaxel for metastatic castration resistant prostate cancer after docetaxel and androgensignaling-targeted inhibitor resistance

8 39 1

Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles

Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles

11 42 1

A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential

10 54 0

Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer

Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer

10 31 1

Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer

Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer

14 64 1

CLASP2 is involved in the EMT and early progression after transurethral resection of the bladder tumor

CLASP2 is involved in the EMT and early progression after transurethral resection of the bladder tumor

10 39 1

A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: Trends in clinical presentation and management of the disease

A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: Trends in clinical presentation and management of the disease

11 59 1

Both comorbidity and worse performance status are associated with poorer overall survival after external beam radiotherapy for prostate cancer

Both comorbidity and worse performance status are associated with poorer overall survival after external beam radiotherapy for prostate cancer

8 84 0

Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease

Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease

10 63 0

Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance

Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance

11 69 1

The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: Possible link to disease early lesion

The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: Possible link to disease early lesion

10 68 1

Review of metastatic colorectal cancer treatment pathways and early clinical experience of trifluridine/tipiracil in the UK named patient programme

Review of metastatic colorectal cancer treatment pathways and early clinical experience of trifluridine/tipiracil in the UK named patient programme

8 39 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.